Advanced Neuroendocrine Tumors Clinical Trials

TRIAL ALERTS

Advanced Neuroendocrine Tumors Clinical Trials

Thank you for your interest in clinical trials for Advanced Neuroendocrine Tumors

Please click "Search" to find Advanced Neuroendocrine Tumors clinical trials and medical research studies.

If you receive too many study listings you may enter your zip code to find the locations closest to you.

Keywords:
AND/OR
Zip Code:
Distance:

Results from Clinical Connection:

(Hide Results...)

Your search returned no results. Get alerts when studies become available.

Results from other databases:

(Show Results...)

Your search returned 6 studies. (Get alerts for new studies):

Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)

Conditions: Neuroendocrine Tumors

2 Locations available

Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That C

Conditions: Islet Cell Tumor - Pancreatic Cancer

292 Locations available

Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma, Gastrointestinal Stromal Tumors an

Conditions: Advanced Renal Cell Carcinoma - Gastrointestinal Stromal Tumors - Pancreatic Neuroendocrine Tumors

1 Location available

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom

Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer

8 Locations available

Everolimus Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (Gastro

Conditions: Advanced NET of GI Origin - Advanced NET of Lung Origin - Neuroendocrine Tumors

2 Locations available

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

Conditions: Pancreatic Alpha Cell Carcinoma - Pancreatic Beta Islet Cell Carcinoma - Pancreatic Delta Cell Carcinoma - Pancreatic G-cell Carcinoma - Recurrent Islet Cell Carcinoma

1 Location available

Didn't find what you were looking for? Try these alternatives:

Become A Member: To be notified of upcoming clinical trials in your area please create a free member account.
Browse Studies: If you would like to browse all US clinical trials please Browse Clinical Trials.
Message Board: Join the discussion in our Health and Clinical Trials Message Board.

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.

TRIAL ALERTS

COMMUNITY

HEALTH NEWS

RSS FEEDS

ABOUT TRIALS

BLOGS

LINK TO US

Searching...

Advanced Neuroendocrine Tumors Clinical Trials